ProSomnus, Inc. (OSAPQ)
OTCMKTS: OSAPQ · Delayed Price · USD
0.0060
-0.0010 (-14.29%)
Jul 26, 2024, 9:30 AM EDT - Market closed
ProSomnus Employees
ProSomnus had 136 employees as of December 31, 2023. The number of employees increased by 7 or 5.43% compared to the previous year.
Employees
136
Change (1Y)
7
Growth (1Y)
5.43%
Revenue / Employee
$203,324
Profits / Employee
-$177,169
Market Cap
104.37K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 136 | 7 | 5.43% |
| Dec 31, 2022 | 129 | 34 | 35.79% |
| Dec 31, 2021 | 95 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
OSAPQ News
- 2 months ago - ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society - GlobeNewsWire
- 2 months ago - ProSomnus Announces Strong First Quarter 2024 Revenue Growth - GlobeNewsWire
- 2 months ago - ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting - GlobeNewsWire
- 2 months ago - Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices - GlobeNewsWire